KB
Healthcare & Life Sciences
KAHR Bio
Israelkahrbio.base44.app/
KAHR Bio is a Healthcare & Life Sciences startup based in Israel, most recent round Series B.
Activeseries-b
series-b
Stage
About KAHR Bio
KAHR Bio is a startup based in Israel. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences.
KAHR Bio develops multifunctional immunotherapy drug candidates, including bispecific T-cell engagers targeting CD47 and 4-1BB pathways, for treating difficult-to-treat cancers such as metastatic microsatellite stable colorectal cancer and non-small cell lung cancer.
Explore KAHR Bio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.